WO45654 A Phase III, Multicenter, Randomized, Double-blined, Placebo-controlled study evaluation the efficacy and safety of Inavolisib plus a CKD4/6 inhibitor and Letrozole vs Placebo plus CDK4/6 Inhibitor and Letrozole in patients with Endocrine Sensitive PIK3CA-Mutated, Hormone Receptor +, Her 2 -, Advanced Breast Cancer

  • Phase III
  • Trial Category: Breast

Contact(s)

Mary Beth Wilwerding, RN   Admin@NEcancertrials.com

Location(s)

Available at Nebraska Cancer Specialists, Omaha and Grand Island, NE locations

Interested in More Information?

Please fill out the form below. Someone will get back to you as soon as possible.

"*" indicates required fields

Name*